Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B-Cell Depleting Treatment in Multiple Sclerosis.

Autor: Benkert P; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Maleska Maceski A; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Schaedelin S; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Oechtering J; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Zadic A; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Vilchez Gomez JF; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Melie-Garcia L; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.; Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland., Cagol A; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.; Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland., Galbusera R; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.; Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland., Subramaniam S; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland., Lorscheider J; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Galli E; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Mueller J; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.; Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland., Fischer-Barnicol B; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Achtnichts L; Department of Neurology, Cantonal Hospital Aarau, Aarau, Switzerland., Findling O; Department of Neurology, Cantonal Hospital Aarau, Aarau, Switzerland., Lalive PH; Department of Clinical Neurosciences, Division of Neurology, and Department of Medicine, Translational Biomarker Group, Geneva, Switzerland.; Diagnostic Department, Division of Laboratory Medicine, Geneva University Hospital, Geneva, Switzerland.; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Bridel C; Department of Clinical Neurosciences, Division of Neurology, and Department of Medicine, Translational Biomarker Group, Geneva, Switzerland., Uginet M; Department of Clinical Neurosciences, Division of Neurology, and Department of Medicine, Translational Biomarker Group, Geneva, Switzerland., Müller S; Department of Neurology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland., Pot C; Service of Neurology and Laboratories of Neuroimmunology, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Mathias A; Service of Neurology and Laboratories of Neuroimmunology, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Du Pasquier R; Service of Neurology and Laboratories of Neuroimmunology, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Salmen A; Department of Neurology, St Josef-Hospital Bochum, Ruhr-University Bochum, Bochum, Germany., Hoepner R; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Chan A; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Disanto G; Multiple Sclerosis Center, Neurocenter of Southern Switzerland, EOC, Lugano, Switzerland., Zecca C; Multiple Sclerosis Center, Neurocenter of Southern Switzerland, EOC, Lugano, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland., D'Souza M; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Hemkens LG; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland., Yaldizli Ö; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Derfuss T; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Roth P; Department of Neurology and Clinical Neuroscience Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Gobbi C; Multiple Sclerosis Center, Neurocenter of Southern Switzerland, EOC, Lugano, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland., Brassat D; Novartis Pharma AG, Basel, Switzerland.; Department of Neurology, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France., Tackenberg B; Department of Neurology, Philipps-University, Marburg, Germany.; F. Hoffmann-La Roche, Basel, Switzerland., Pedotti R; F. Hoffmann-La Roche, Basel, Switzerland., Raposo C; F. Hoffmann-La Roche, Basel, Switzerland., Oksenberg J; Department of Neurology and Weill Institute for Neurosciences, University of California, San Francisco, CA, USA., Wiendl H; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany., Berger K; Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany., Hermesdorf M; Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany., Piehl F; Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.; Center for Neurology, Academic Specialist Center, Stockholm Health Services, Stockholm, Sweden., Conen D; Population Health Research Institute, McMaster University, Hamilton, Canada., Buser A; Regional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland., Kappos L; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Khalil M; Department of Neurology, Medical University of Graz, Graz, Austria., Granziera C; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.; Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland., Abdelhak A; Department of Neurology and Weill Institute for Neurosciences, University of California, San Francisco, CA, USA., Leppert D; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Willemse EAJ; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland., Kuhle J; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.

Publikováno v: Annals of neurology [Ann Neurol] 2024 Oct 16. Date of Electronic Publication: 2024 Oct 16.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tunneling and conformational preferences in racemic- and meso-2,4-pentanediol: A rotational spectroscopic and theoretical investigation.

Autor: Carlson CD; Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada., D'Souza M; Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada., Ma J; Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada., Mort AN; Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada., Insausti A; Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada.; Departamento de Química Física, Universidad del País Vasco (UPV/EHU), Barrio Sarriena s/n, Leioa, Spain.; Instituto Biofisika (UPV/EHU, CSIC), Barrio Sarriena s/n, Leioa, Spain., Xu Y; Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada.

Publikováno v: The Journal of chemical physics [J Chem Phys] 2024 Dec 28; Vol. 161 (24).

Neurometabolite and cognitive changes in hypothyroid patients in response to treatment: In-vivo ¹ H MRS study.

Autor: Kumar M; NMR Research Centre, Institute of Nuclear Medicine and Allied Sciences (INMAS), DRDO, Delhi, India; Department of NMR & MRI Facility, All India Institute of Medical Sciences, New Delhi, India., Singh S; NMR Research Centre, Institute of Nuclear Medicine and Allied Sciences (INMAS), DRDO, Delhi, India; Centre for Brain Research, Indian Institute of Science, Bengaluru, India., Rana P; NMR Research Centre, Institute of Nuclear Medicine and Allied Sciences (INMAS), DRDO, Delhi, India., D'souza M; NMR Research Centre, Institute of Nuclear Medicine and Allied Sciences (INMAS), DRDO, Delhi, India., Kumaran SS; Department of NMR & MRI Facility, All India Institute of Medical Sciences, New Delhi, India., Sekhri T; Thyroid Research Centre, Institute of Nuclear Medicine and Allied Sciences (INMAS), DRDO, Delhi, India., Khushu S; NMR Research Centre, Institute of Nuclear Medicine and Allied Sciences (INMAS), DRDO, Delhi, India; Centre for Ayurveda Biology and Holistic Nutrition (CABHN), The University of Trans-Disciplinary Health Sciences and Technology, Bengaluru, India. Electronic address: skhushu@yahoo.com.

Publikováno v: Neurochemistry international [Neurochem Int] 2024 Dec 09; Vol. 182, pp. 105915. Date of Electronic Publication: 2024 Dec 09.

Truth to Action: Lived Experiences of Indigenous Healthcare Professionals Redressing Indigenous-Specific Racism.

Autor: Bourque Bearskin ML; Beaver Lake Cree Nation, BC IHNR Chair, Associate Professor, School of Nursing, University of Victoria, Kamloops, BC, Canada., Seymour MLC; Tk'emlúps te Secwépemc (Secwepemc Nation), Knowledge Holder BC IHNR, Kamloops, BC, Canada., Melnyk R; St'uxwtews (Secwépemc Nation), Executive Director, Indigenous Health & Cultural Safety, BC Mental Health & Substance Use Services, Kamloops, BC, Canada., D'Souza M; Associate Professor, School of Nursing, Thompson Rivers University, British Columbia, Kamloops, BC, Canada., Sturm J; Pellt'iq't First Nation, Senior Practice Leader, Chee Mamuk, BC Centre for Disease Control, Kamloops, BC, Canada., Mooney T; Métis Nation BC Citizen and guest on Syilx Lands, Regional Human Resources Director, BC First Nations Justice Council, Kamloops, BC, Canada., Hunter-Porter NR; St'uxwstews (Secwépemc Nation), Research Associate, BC IHNR, Clinical Nurse Specialist, Kamloops, BC, Canada., Ward AE; Upper Nicola Band (Syilx Nation), Research Participant and Advisory Member, Practice Lead, MHSU NetWork, Victoria, BC, Canada., Bell B; Research Associate, BC IHNR Chair, University of Victoria, Victoria, BC, Canada.

Publikováno v: The Canadian journal of nursing research = Revue canadienne de recherche en sciences infirmieres [Can J Nurs Res] 2024 Oct 04, pp. 8445621241282784. Date of Electronic Publication: 2024 Oct 04.